• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Long Term Use of Proton Pump Inhibitors...Is it Safe?

Program Type

OnDemand

Credits

1.25 Contact Hour(s)

Release Date

Wednesday, June 20, 2018

Offline Date:

Monday, December 21, 2020

ACPE Expiration Date

Monday, December 21, 2020

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$4.00

  • Overview

    Over the last number of years and even most recently observational studies have surfaced examining the long term safety of proton pump inhibitors, most notably the prescription PPIs. Some of the long term effects that have been observed in these studies include dementia, fractures, kidney disease, nutrient malabsorption, infections and most recently death. Despite all of the data that has been published it is important to look more closely at these studies since they are only observational and not randomized controlled trials. Unfortunately this information is readily available to the public via the media and it continues to pose concerns for not only patients but clinicians as well. It is important for pharmacists to be educated on this topic so they can appropriately communicate with their patients and prescribers on this class of medication.

    Rating


    Handouts

    Slide Document:   17222H01_4pp.pdf
    Slide Document:   17222H01_2pp.pdf

    Financial Support By

    PharmCon, Inc.
  • Nurse

    Review the indication and safety profile of the currently FDA approved prescription proton pump inhibitors
    Identify the long term safety concerns of the class of PPIs including the mechanism of action
    Keeping in mind the features of observational studies, analyze the study data pertaining to PPIs
    Based on the conclusions of observational studies, communicate findings with patients and other clinicians


    Pharmacist

    Review the indication and safety profile of the currently FDA approved prescription proton pump inhibitors
    Identify the long term safety concerns of the class of PPIs including the mechanism of action
    Keeping in mind the features of observational studies, analyze the study data pertaining to PPIs
    Based on the conclusions of observational studies, communicate findings with patients and other clinicians


    Pharmacy Technician

    Review the indications for the current FDA approved prescription and nonprescription proton pump inhibitors (PPIs)
    Recognize warnings associated with the use of PPIs that are listed in the product package inserts
    Distinguish between randomized controlled studies trials and observational studies

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-17-222-H01-P

    Pharmacist 0798-0000-17-222-H01-P

    Pharmacy Technician 0798-0000-17-222-H01-T

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

  • Faculty

    Brooke Fidler, PharmD
    Associate Professor, LIU Pharmacy, Arnold & Marie Schwartz College of Pharmacy and Health Sciences




HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.